Average Co-Inventor Count = 9.89
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Gilead Sciences, Inc. (33 from 923 patents)
2. Abbvie Inc. (9 from 822 patents)
3. Novartis Vaccines & Diagnostics, Gmbh (5 from 245 patents)
4. Novartis Ag (1 from 3,923 patents)
48 patents:
1. 12421235 - Bridged tricyclic carbamoylpyridone compounds and uses thereof
2. 12227520 - Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
3. 12202842 - MCL1 inhibitors
4. 12187734 - Substituted pyridotriazine compounds and uses thereof
5. 12162844 - MCL-1 inhibitors
6. 12054496 - Bridged tricyclic carbamoylpyridone compounds and uses thereof
7. 12024528 - Bridged tricyclic carbamoylpyridone compounds and uses thereof
8. 11897892 - Substituted pyridotriazine compounds and uses thereof
9. 11667652 - MCL1 inhibitors
10. 11643400 - MCL-1 inhibitors
11. 11613546 - Substituted pyridotriazine compounds and uses thereof
12. 11548902 - Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
13. 11352329 - HIV protease inhibitors
14. 11110091 - Modulators of toll-like receptors
15. 11084832 - Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use